TOMDF (Todos Medical) EBITDA Margin %: -111.65% (As of Sep. 2022)


What is Todos Medical EBITDA Margin %?

Todos Medical TOMDF -90.00% EBITDA Margin % is -111.65% as of Sep. 2022.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Todos Medical's EBITDA for the three months ended in Sep. 2022 was $-2.14 Mil. Todos Medical's Revenue for the three months ended in Sep. 2022 was $1.91 Mil. Therefore, Todos Medical's EBITDA margin for the quarter that ended in Sep. 2022 was -111.65%.

Todos Medical  (OTCPK:TOMDF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Todos Medical EBITDA Margin % Related Terms

Todos Medical EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Todos Medical's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Todos Medical EBITDA Margin % Chart

Todos Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EBITDA Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 -313.14 -114.01

Todos Medical Quarterly Data
Dec15 Dec16 Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -357.82 -243.86 -56.98 -116.11 -111.65

TOMDF vs NDRA, IDXG, STRR: EBITDA Margin % Comparison

For the Diagnostics & Research subindustry, Todos Medical's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Todos Medical EBITDA Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Todos Medical's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Todos Medical's EBITDA Margin % falls into.


Todos Medical EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Todos Medical's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-13.944/12.23
=-114.01 %

Todos Medical's EBITDA Margin % for the quarter that ended in Sep. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-2.137/1.914
=-111.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -111.65% mean?
Todos Medical (TOMDF) has a EBITDA Margin % of -111.65% as of Sep. 2022. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Todos Medical and its competitors.
Is Todos Medical's EBITDA Margin % too high?
Todos Medical's current EBITDA Margin % is -111.65%.
How does Todos Medical's EBITDA Margin % compare to NDRA and IDXG?
Todos Medical's EBITDA Margin % of -111.65% can be compared against companies in the Medical Diagnostics & Research industry. The industry median EBITDA Margin % is 5.20. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Diagnostics & Research company?
The median EBITDA Margin % among Medical Diagnostics & Research companies is 5.20, based on 204 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Todos Medical and its competitors. For the Medical Diagnostics & Research industry, the median EBITDA Margin % is 5.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Todos Medical's current EBITDA Margin % is -111.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Todos Medical stock overvalued right now?
Todos Medical (TOMDF) has a current EBITDA Margin % of -111.65%. The current EBITDA Margin % is -111.65%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Todos Medical (TOMDF), the current EBITDA Margin % is -111.65% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Todos Medical Business Description

Address 121 Derech Menachem Begin, 30th Floor, Tel Aviv, ISR, 6701203
Todos Medical Ltd is an in vitro diagnostics company. Its operating segments are Breast Cancer Test, Alzheimer's, and COVID-19 testing. The company generates all of its revenue from the United States.